Navigation Links
PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
Date:1/29/2013

The GAAP tax rate for the second quarter of Fiscal Year 2013 was 31.7% compared with 31.2% in the prior year quarter.  Excluding special items as detailed in the financial charts within this press release, the adjusted tax rate in the December 2012 quarter was 23.3%, compared with 30.5% in the December 2011 quarter.  The lower adjusted tax rate in the second quarter of Fiscal Year 2013 was the result of a beneficial change in the mix of actual and forecasted pre-tax income.  Going forward, the Company expects the GAAP tax rate for the third quarter of Fiscal Year 2013 to be approximately 26.0%, and approximately 30% in the fourth quarter.  The projected rates include the impact of recent tax law changes in the United States (which are retroactive to July 1, 2012) and which were enacted in January 2013, as well as the beneficial change in mix of pre-tax income, mentioned previously.  The projected tax rate in the third quarter includes the retroactive benefit of the recent tax law change for the first and second quarters of Fiscal Year 2013.

During the second quarter, the Company purchased a total of approximately 1.5 million shares of its common stock for $45.2 million under its previously announced $200 million Share Repurchase Program, which was implemented in September 2012.  All of these shares were purchased in the open market through a 10b5-1 plan, which was completed in the second quarter.  Taking into account additional activity in the first quarter, as of December 31, 2012, approximately $100 million remained available under the Share Repurchase Program for the purchase of additional shares.  The Company is currently planning the next phase of the program.

On a segment basis, service revenue for the second quarter of Fiscal Year 2013 was $320.6 million in Clinical Research Services (CRS), $49.3 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $52.2 million in Perce
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
2. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
3. Parexel Invites Public To Listen To Live Webcast Of Its Investor Day May 31, 2012
4. PAREXEL Chairman And CEO To Ring The Bell At The NASDAQ Stock Market Opening
5. PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day
6. PAREXEL International To Present At NASDAQ OMX Investor Conference
7. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call
8. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
9. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
10. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
11. PAREXEL International to Present at Robert Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 31, 2014  Zacks.com announces the list of stocks featured in ... the latest news and events impacting stocks and the financial markets. ... AMGN - Free Report ), Celgene (Nasdaq: CELG ... - Free Report ), Market Vectors Biotech ETF (AMEX: ... ETF (AMEX: XBI - Free Report ). ...
(Date:10/31/2014)... , October 31, 2014 Multigate Medical ... patents of B. Braun Melsungen AG (B. Braun) by selling ... safety IV catheters manufactured by Poly Medicure Ltd (Polymed). The ... proceeding number VID 463 of 2013 can be ... detailed judgment, Multigate was found to have infringed claim 1 ...
(Date:10/31/2014)... Oct. 30, 2014 Electronic prescribing ... transmission of prescription related information between prescriber, ... allows a physician and nurse practitioner to ... medication error occurs during pharmacy operations. E-Prescribing ... It provides complete medical lists, conducts all ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2
... Building Comprehensive HIV/AIDS Care Programs in,Resource-Limited Settings" ... Health,Experts, MEXICO CITY, Aug. 5 ... from the "A Day in the Life ... and others, unveiled today a comprehensive guide ...
... and safety of once-daily TMC278 in ... treatment-naive adults with HIV-1 ... IIb data from Tibotec,Pharmaceuticals Ltd. provides additional information on ... reverse transcriptase inhibitor (NNRTI), as part of HIV,combination therapy ...
Cached Medicine Technology:Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City 2Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City 3Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008 2
(Date:10/31/2014)... Daily Gossip writes in its Xtreme Fat Loss review that ... loss program ever developed. It promises to provide users the ... no wonder after all that this has become the most ... and workout fat loss program was created by Joel Marion, ... the author of this fat loss system, the method can ...
(Date:10/31/2014)... Activz Whole-Food Nutrition is ... line offering natural silver healing support† in liquid supplements, ... silver has been used to support natural healing, and ... the most advanced version available. This latest formula, backed ... that supports the existing healing mechanisms in the human ...
(Date:10/31/2014)... terms of duration of treatment and cost, patients ... accelerated partial breast irradiation (APBI) with proton therapy ... research from The University of Texas MD Anderson ... cost analysis study based on typical patient characteristics, ... charges for eight different types of partial and ...
(Date:10/31/2014)... The Suspension Revolution review published by Daily ... by Dan Long, a suspension training specialist. , ... and life coach. The author of this program claims ... not impossible , The Suspension Revolution review reveals that ... promises efficiency when it comes to burning fat, building ...
(Date:10/31/2014)... New York, NY (PRWEB) October 31, 2014 ... on one of the most remarkable gifts of life ... a platform for matching extraordinary surrogate mothers and donors ... stories about individuals in unforeseen circumstances. , It’s a ... sperm donors, surrogacy agencies, surrogacy lawyers, and fertility clinics ...
Breaking Medicine News(10 mins):Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 3
... the rage among doctors treating patients with blocked arteries, ... link them with a low, but serious risk of ... research by American scientists in two different studies published ... that many doctors have stretched the limit of their ...
... recalling 1.75 quart cartons of Mayfield Turtle Tracks ice cream ... code of 75243-20120. The recall was initiated because the affected ... No other Mayfield Dairy Farms products are involved in this ... the risk of a serious reaction if they consume this ...
... may be the most promising area of research for ... according to a new review in the International Journal ... confirmed the role of hormone therapy in recurrent ovarian ... review author Dr. Siqing Fu, an assistant professor of ...
... its efforts to prevent the spread of drug-resistant ... the public health sector and providing health care ... Skweyiya said at a media briefing on Tuesday, ... that the country is expanding hospital isolation wards ...
... Ministry of External Affairs, informed the Lok Sabha today that ... passports. ,At first these passports will be ... the end of 2007. Based on the experience gained from this ... the ordinary category by the end of 2008. , ...
... the thought that doctors could be on the payrolls of ... rampant in many developing countries. But things are no difference ... repeated visits by representatives of pharmaceutical firms resulted in prescription ... venerable New York Times wrote, doctors who have close relationships ...
Cached Medicine News:Health News:Studies Reveal Inappropriate Use Of Drug-Coated Stents 2Health News:Studies Reveal Inappropriate Use Of Drug-Coated Stents 3Health News:South Africa Increasing Efforts To Contain Drug-Resistant TB, Minister Says 2Health News:Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics 2Health News:Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics 3Health News:Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics 4
... electronic, motorized rotary microtomes ... applications of paraffin, semi-thin ... specimens in clinical, research, ... instruments display extra-ordinary ergonomic ...
... Leica RM2125 microtome comes in two different ... RM2125 RT. All RM2125 versions are now ... entering the precision micrometer feeding system. The ... trimming function and specimen retraction as additional ...
... Leica SM2500 large scale heavy-duty sectioning system is ... sectioning techniques a real working animal. ,Large ... hard materials such as bone or teeth and ... The wide range of accessories, specially designed for ...
... and industrial applications, the Leica SM2400 is ... applications in all laboratories where paraffin or ... Its sturdy construction lends it qualities that ... of the system, such as a sledge ...
Medicine Products: